Hattori Yoshitsugu, Huang Po-Cheng, Chang Chun-Shin, Chen Yu-Ray, Lo Lun-Jou
From the Craniofacial Center, Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital.
Graduate Institute of Dental and Craniofacial Science, Chang Gung University.
Plast Reconstr Surg. 2024 Mar 1;153(3):697-705. doi: 10.1097/PRS.0000000000010597. Epub 2023 Apr 26.
Facial palsy after orthognathic surgery is an uncommon but serious complication causing dissatisfaction and affecting quality of life. The occurrence could be underreported. Surgeons need to recognize this issue regarding the incidence, causative mechanism, managements, and outcome.
A retrospective review of orthognathic surgery records between January of 1981 and May of 2022 was conducted in the authors' craniofacial center. Patients who developed facial palsy after the surgery were identified, and demographics, surgical methods, radiologic images, and photographs were collected.
A total of 20,953 sagittal split ramus osteotomies (SSROs) were performed in 10,478 patients. Twenty-seven patients developed facial palsy, resulting in an incidence of 0.13% per SSRO. In a comparison of SSRO technique, the Obwegeser-Dal Pont technique using osteotome for splitting had higher risk of facial palsy than the Hunsuck technique using the manual twist splitting ( P < 0.05). The severity of facial palsy was complete in 55.6% of patients and incomplete in 44.4%. All patients were treated conservatively, and 88.9% attained full recovery in a median duration of 3 months [interquartile range (IQR), 2.75 to 6 months] after surgery, whereas 11.1% attained partial recovery. Initial severity of facial palsy predicted the timing of recovery, with incomplete palsy patients having faster median recovery (3 months; IQR, 2 to 3 months) than the complete palsy patients (6 months; IQR, 4 to 6.25 months) ( P = 0.02).
The incidence of facial palsy after orthognathic surgery was 0.13%. Intraoperative nerve compression was the most likely causative mechanism. Conservative treatment is the mainstay of therapeutic strategy, and full functional recovery was anticipated.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, IV.
正颌外科手术后的面瘫是一种罕见但严重的并发症,会导致患者不满并影响生活质量。其发生率可能被低估。外科医生需要认识到有关发病率、致病机制、治疗方法和预后的这个问题。
作者所在的颅面中心对1981年1月至2022年5月期间的正颌外科手术记录进行了回顾性研究。确定术后发生面瘫的患者,并收集其人口统计学资料、手术方法、影像学图像和照片。
共对10478例患者进行了20953次下颌升支矢状劈开截骨术(SSRO)。27例患者发生面瘫,导致每次SSRO的发生率为0.13%。在SSRO技术比较中,使用骨凿劈开的Obwegeser-Dal Pont技术比使用手动扭转劈开的Hunsuck技术发生面瘫的风险更高(P<0.05)。55.6%的患者面瘫严重程度为完全性,44.4%为不完全性。所有患者均接受保守治疗,88.9%的患者在术后中位3个月[四分位间距(IQR),2.75至6个月]时完全恢复,而11.1%的患者部分恢复。面瘫的初始严重程度可预测恢复时间,不完全性面瘫患者的中位恢复时间(3个月;IQR,2至3个月)比完全性面瘫患者(6个月;IQR,4至6.25个月)更快(P=0.02)。
正颌外科手术后面瘫的发生率为0.13%。术中神经受压是最可能的致病机制。保守治疗是治疗策略的主要手段,预期可实现完全功能恢复。
临床问题/证据级别:风险,IV级。